Home/Tridek-One/Jean-François Arrighi, PhD
JA

Jean-François Arrighi, PhD

CSO

Tridek-One

Tridek-One Pipeline

DrugIndicationPhase
CD31-ITAM Bispecific PlatformAutoimmune and Inflammatory DiseasesPre-clinical